AI assistant
PROCEPT BioRobotics Corp — Director's Dealing 2024
Feb 9, 2024
31665_dirs_2024-02-09_ca782d07-cf46-497e-85b0-c24f373ca581.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PROCEPT BioRobotics Corp (PRCT)
CIK: 0001588978
Period of Report: 2024-02-07
Reporting Person: Nouri Alaleh (EVP, CLO, CORP. SEC.)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-02-07 | Common Stock | M | 5306 | $5.18 | Acquired | 52657 | Direct |
| 2024-02-07 | Common Stock | S | 5306 | $49.9535 | Disposed | 47351 | Direct |
| 2024-02-09 | Common Stock | M | 14694 | $5.18 | Acquired | 62045 | Direct |
| 2024-02-09 | Common Stock | S | 14694 | $49.9737 | Disposed | 47351 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-02-07 | Stock Option (Right to Buy) | $5.18 | M | 5306 | Disposed | 2030-08-08 | Common Stock (5306) | Direct |
| 2024-02-09 | Stock Option (Right to Buy) | $5.18 | M | 14694 | Disposed | 2030-08-08 | Common Stock (14694) | Direct |
Footnotes
F1: All transactions reported here were affected pursuant to Rule 10b5-1 Plan adopted by the reporting person on 3/7/2023.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.95 to $50.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.95 to $50.02, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
F4: The Stock option was granted on August 10, 2020 and vested 12.5% on the six month anniversary of August 1, 2020 and the remainder on each monthly anniversary over a three and a half year period, subject continued employment or service to the Issuer through the applicable vesting date.